Pre-made Pateclizumab benchmark antibody ( Whole mAb, anti-LTA therapeutic antibody, Anti-LT/TNFB/TNFSF1/TNLG1E Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-430
Pre-Made Pateclizumab biosimilar, Whole mAb, Anti-LTA Antibody: Anti-LT/TNFB/TNFSF1/TNLG1E therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Pateclizumab (MLTA3698A) is an immunomodulator. It binds to lymphotoxin alpha.
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
|Catalog No.||Package||List Price(In USD)||Discount off||Discount Price|
Size： 1mg | 10mg | 100mg
|Products Name (INN Index)||Pre-Made Pateclizumab biosimilar, Whole mAb, Anti-LTA Antibody: Anti-LT/TNFB/TNFSF1/TNLG1E therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Phase-II|
|100% SI Structure||4mxv:HL:YX:FE/4mxw:HL:WV|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Conditions Discontinued||Rheumatoid arthritis|